Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
SBRT to adrenal metastases provides high local control with minimal toxicity.

Advances in radiation oncology

Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, Flynn RT, Bhatia SK, Smith MC, Buatti JM, Allen BG.
PMID: 29204525
Adv Radiat Oncol. 2017 Aug 04;2(4):581-587. doi: 10.1016/j.adro.2017.07.011. eCollection 2017.

PURPOSE: The adrenal glands are a common site of metastases because of their rich blood supply. Previously, adrenal metastases were treated with systemic chemotherapy or, more rarely, with surgical resection or palliative radiation therapy. Stereotactic body radiation therapy (SBRT)...

Cite
Plichta K, Camden N, Furqan M, et al. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol. 2017;2(4):581-587doi: 10.1016/j.adro.2017.07.011.
Plichta, K., Camden, N., Furqan, M., Hejleh, T. A., Clamon, G. H., Zhang, J., Flynn, R. T., Bhatia, S. K., Smith, M. C., Buatti, J. M., & Allen, B. G. (2017). SBRT to adrenal metastases provides high local control with minimal toxicity. Advances in radiation oncology, 2(4), 581-587. https://doi.org/10.1016/j.adro.2017.07.011
Plichta, Kristin, et al. "SBRT to adrenal metastases provides high local control with minimal toxicity." Advances in radiation oncology vol. 2,4 (2017): 581-587. doi: https://doi.org/10.1016/j.adro.2017.07.011
Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, Flynn RT, Bhatia SK, Smith MC, Buatti JM, Allen BG. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol. 2017 Aug 04;2(4):581-587. doi: 10.1016/j.adro.2017.07.011. eCollection 2017. PMID: 29204525; PMCID: PMC5707423.
Copy Download .nbib Format: NLM
O.

Cancer cell

Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Kauffman EPS, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG.
PMID: 28810149
Cancer Cell. 2017 Aug 14;32(2):268. doi: 10.1016/j.ccell.2017.07.008.

No abstract available.

Cite
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, et al. O. Cancer Cell. 2017;32(2):268doi: 10.1016/j.ccell.2017.07.008.
Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Abu Hejleh, T., Berg, D. J., Zhang, J., Keech, J., Parekh, K. R., Bhatia, S., Monga, V., Bodeker, K. L., Ahmann, L., Vollstedt, S., Brown, H., Kauffman, E. P. S., Schall, M. E., Hohl, R. J., Clamon, G. H., Greenlee, J. D., Howard, M. A., Schultz, M. K., Smith, B. J., Riley, D. P., Domann, F. E., Cullen, J. J., Buettner, G. R., Buatti, J. M., Spitz, D. R., & Allen, B. G. (2017). O. Cancer cell, 32(2), 268. https://doi.org/10.1016/j.ccell.2017.07.008
Schoenfeld, Joshua D, et al. "O." Cancer cell vol. 32,2 (2017): 268. doi: https://doi.org/10.1016/j.ccell.2017.07.008
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Kauffman EPS, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG. O. Cancer Cell. 2017 Aug 14;32(2):268. doi: 10.1016/j.ccell.2017.07.008. PMID: 28810149.
Copy Download .nbib Format: NLM
Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts.

Methods (San Diego, Calif.)

Sahadevan P, Allen BG.
PMID: 33838270
Methods. 2021 Apr 08; doi: 10.1016/j.ymeth.2021.04.004. Epub 2021 Apr 08.

Cardiac fibroblasts play a critical role in extracellular matrix homeostasis, wound healing, and cardiac interstitial fibrosis: the latter being a pathophysiological response to a chronic increase in afterload. Using a standard protocol to isolate cardiac fibroblasts and maintain them...

Cite
Sahadevan P, Allen BG. Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts. Methods. 2021;doi: 10.1016/j.ymeth.2021.04.004.
Sahadevan, P., & Allen, B. G. (2021). Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts. Methods (San Diego, Calif.), . https://doi.org/10.1016/j.ymeth.2021.04.004
Sahadevan, Pramod, and Allen, Bruce G. "Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts." Methods (San Diego, Calif.) vol. (2021). doi: https://doi.org/10.1016/j.ymeth.2021.04.004
Sahadevan P, Allen BG. Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts. Methods. 2021 Apr 08; doi: 10.1016/j.ymeth.2021.04.004. Epub 2021 Apr 08. PMID: 33838270.
Copy Download .nbib Format: NLM
Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma.

Frontiers in oncology

Seyedin SN, Gannon MK, Plichta KA, Abushahin L, Berg DJ, Arshava EV, Parekh KR, Keech JC, Caster JM, Welsh JW, Allen BG.
PMID: 32850412
Front Oncol. 2020 Jul 31;10:1311. doi: 10.3389/fonc.2020.01311. eCollection 2020.

No abstract available.

Cite
Seyedin SN, Gannon MK, Plichta KA, et al. Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma. Front Oncol. 2020;10:1311doi: 10.3389/fonc.2020.01311.
Seyedin, S. N., Gannon, M. K., Plichta, K. A., Abushahin, L., Berg, D. J., Arshava, E. V., Parekh, K. R., Keech, J. C., Caster, J. M., Welsh, J. W., & Allen, B. G. (2020). Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma. Frontiers in oncology, 101311. https://doi.org/10.3389/fonc.2020.01311
Seyedin, Steven N, et al. "Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma." Frontiers in oncology vol. 10 (2020): 1311. doi: https://doi.org/10.3389/fonc.2020.01311
Seyedin SN, Gannon MK, Plichta KA, Abushahin L, Berg DJ, Arshava EV, Parekh KR, Keech JC, Caster JM, Welsh JW, Allen BG. Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma. Front Oncol. 2020 Jul 31;10:1311. doi: 10.3389/fonc.2020.01311. eCollection 2020. PMID: 32850412; PMCID: PMC7412633.
Copy Download .nbib Format: NLM
Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis.

Journal of thoracic disease

Furqan M, Tien YY, Schroeder MC, Parekh KR, Keech J, Allen BG, Thomas A, Zhang J, Clamon G, Abu Hejleh T.
PMID: 30505493
J Thorac Dis. 2018 Oct;10(10):5850-5859. doi: 10.21037/jtd.2018.09.141.

BACKGROUND: The optimal surgery for resectable pulmonary typical carcinoid (TC), e.g., lobar resection (L-R) METHODS: The Surveillance, Epidemiology, and End Results (SEER) Program was used to select patients ≥66 years old, and diagnosed between 2000 and 2012 with pulmonary...

Cite
Furqan M, Tien YY, Schroeder MC, et al. Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis. J Thorac Dis. 2018;10(10):5850-5859doi: 10.21037/jtd.2018.09.141.
Furqan, M., Tien, Y. Y., Schroeder, M. C., Parekh, K. R., Keech, J., Allen, B. G., Thomas, A., Zhang, J., Clamon, G., & Abu Hejleh, T. (2018). Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis. Journal of thoracic disease, 10(10), 5850-5859. https://doi.org/10.21037/jtd.2018.09.141
Furqan, Muhammad, et al. "Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis." Journal of thoracic disease vol. 10,10 (2018): 5850-5859. doi: https://doi.org/10.21037/jtd.2018.09.141
Furqan M, Tien YY, Schroeder MC, Parekh KR, Keech J, Allen BG, Thomas A, Zhang J, Clamon G, Abu Hejleh T. Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis. J Thorac Dis. 2018 Oct;10(10):5850-5859. doi: 10.21037/jtd.2018.09.141. PMID: 30505493; PMCID: PMC6236154.
Copy Download .nbib Format: NLM
Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents.

Cancers

Callaghan CM, Hasibuzzaman MM, Rodman SN, Goetz JE, Mapuskar KA, Petronek MS, Steinbach EJ, Miller BJ, Pulliam CF, Coleman MC, Monga VV, Milhem MM, Spitz DR, Allen BG.
PMID: 32806601
Cancers (Basel). 2020 Aug 12;12(8). doi: 10.3390/cancers12082258.

Historically, patients with localized soft tissue sarcomas (STS) of the extremities would undergo limb amputation. It was subsequently determined that the addition of radiation therapy (RT) delivered prior to (neoadjuvant) or after (adjuvant) a limb-sparing surgical resection yielded equivalent...

Cite
Callaghan CM, Hasibuzzaman MM, Rodman SN, et al. Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents. Cancers (Basel). 2020;12(8)doi: 10.3390/cancers12082258.
Callaghan, C. M., Hasibuzzaman, M. M., Rodman, S. N., Goetz, J. E., Mapuskar, K. A., Petronek, M. S., Steinbach, E. J., Miller, B. J., Pulliam, C. F., Coleman, M. C., Monga, V. V., Milhem, M. M., Spitz, D. R., & Allen, B. G. (2020). Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents. Cancers, 12(8), . https://doi.org/10.3390/cancers12082258
Callaghan, Cameron M, et al. "Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents." Cancers vol. 12,8 (2020). doi: https://doi.org/10.3390/cancers12082258
Callaghan CM, Hasibuzzaman MM, Rodman SN, Goetz JE, Mapuskar KA, Petronek MS, Steinbach EJ, Miller BJ, Pulliam CF, Coleman MC, Monga VV, Milhem MM, Spitz DR, Allen BG. Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents. Cancers (Basel). 2020 Aug 12;12(8). doi: 10.3390/cancers12082258. PMID: 32806601; PMCID: PMC7465163.
Copy Download .nbib Format: NLM
Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer.

Antioxidants (Basel, Switzerland)

Petronek MS, Spitz DR, Allen BG.
PMID: 34573089
Antioxidants (Basel). 2021 Sep 14;10(9). doi: 10.3390/antiox10091458.

Cancer cells preferentially accumulate iron (Fe) relative to non-malignant cells; however, the underlying rationale remains elusive. Iron-sulfur (Fe-S) clusters are critical cofactors that aid in a wide variety of cellular functions (e.g., DNA metabolism and electron transport). In this...

Cite
Petronek MS, Spitz DR, Allen BG. Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer. Antioxidants (Basel). 2021;10(9)doi: 10.3390/antiox10091458.
Petronek, M. S., Spitz, D. R., & Allen, B. G. (2021). Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer. Antioxidants (Basel, Switzerland), 10(9), . https://doi.org/10.3390/antiox10091458
Petronek, Michael S, et al. "Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer." Antioxidants (Basel, Switzerland) vol. 10,9 (2021). doi: https://doi.org/10.3390/antiox10091458
Petronek MS, Spitz DR, Allen BG. Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer. Antioxidants (Basel). 2021 Sep 14;10(9). doi: 10.3390/antiox10091458. PMID: 34573089; PMCID: PMC8465902.
Copy Download .nbib Format: NLM
Quantum chemical insight into the effects of the local electron environment on T.

Scientific reports

Petronek MS, St-Aubin JJ, Lee CY, Spitz DR, Gillan EG, Allen BG, Magnotta VA.
PMID: 34675308
Sci Rep. 2021 Oct 21;11(1):20817. doi: 10.1038/s41598-021-00305-7.

T

Cite
Petronek MS, St-Aubin JJ, Lee CY, et al. Quantum chemical insight into the effects of the local electron environment on T. Sci Rep. 2021;11(1):20817doi: 10.1038/s41598-021-00305-7.
Petronek, M. S., St-Aubin, J. J., Lee, C. Y., Spitz, D. R., Gillan, E. G., Allen, B. G., & Magnotta, V. A. (2021). Quantum chemical insight into the effects of the local electron environment on T. Scientific reports, 11(1), 20817. https://doi.org/10.1038/s41598-021-00305-7
Petronek, M S, et al. "Quantum chemical insight into the effects of the local electron environment on T." Scientific reports vol. 11,1 (2021): 20817. doi: https://doi.org/10.1038/s41598-021-00305-7
Petronek MS, St-Aubin JJ, Lee CY, Spitz DR, Gillan EG, Allen BG, Magnotta VA. Quantum chemical insight into the effects of the local electron environment on T. Sci Rep. 2021 Oct 21;11(1):20817. doi: 10.1038/s41598-021-00305-7. PMID: 34675308; PMCID: PMC8531323.
Copy Download .nbib Format: NLM
Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?.

Nature clinical practice. Oncology

Taal BG, Cats A, van Tinteren H.
PMID: 16757967
Nat Clin Pract Oncol. 2006 Jun;3(6):300-1. doi: 10.1038/ncponc0515.

No abstract available.

Cite
Taal BG, Cats A, van Tinteren H. Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?. Nat Clin Pract Oncol. 2006;3(6):300-1doi: 10.1038/ncponc0515.
Taal, B. G., Cats, A., & van Tinteren, H. (2006). Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?. Nature clinical practice. Oncology, 3(6), 300-1. https://doi.org/10.1038/ncponc0515
Taal, Barbara G, et al. "Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?." Nature clinical practice. Oncology vol. 3,6 (2006): 300-1. doi: https://doi.org/10.1038/ncponc0515
Taal BG, Cats A, van Tinteren H. Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?. Nat Clin Pract Oncol. 2006 Jun;3(6):300-1. doi: 10.1038/ncponc0515. PMID: 16757967.
Copy Download .nbib Format: NLM
Cloning, expression and purification of functionally active human angiopoietin-like protein 2.

SpringerPlus

Farhat N, Mamarbachi AM, Thorin E, Allen BG.
PMID: 25077060
Springerplus. 2014 Jul 03;3:337. doi: 10.1186/2193-1801-3-337. eCollection 2014.

Angiopoietin-like protein 2 (Angptl2) is a secreted glycoprotein that has been implicated in angiogenesis, inflammation and atherosclerosis as well as enhancing the survival of human hematopoietic stem cells. Glycosylation of Angptl2 is required for biological activity and studies of...

Cite
Farhat N, Mamarbachi AM, Thorin E, et al. Cloning, expression and purification of functionally active human angiopoietin-like protein 2. Springerplus. 2014;3:337doi: 10.1186/2193-1801-3-337.
Farhat, N., Mamarbachi, A. M., Thorin, E., & Allen, B. G. (2014). Cloning, expression and purification of functionally active human angiopoietin-like protein 2. SpringerPlus, 3337. https://doi.org/10.1186/2193-1801-3-337
Farhat, Nada, et al. "Cloning, expression and purification of functionally active human angiopoietin-like protein 2." SpringerPlus vol. 3 (2014): 337. doi: https://doi.org/10.1186/2193-1801-3-337
Farhat N, Mamarbachi AM, Thorin E, Allen BG. Cloning, expression and purification of functionally active human angiopoietin-like protein 2. Springerplus. 2014 Jul 03;3:337. doi: 10.1186/2193-1801-3-337. eCollection 2014. PMID: 25077060; PMCID: PMC4112196.
Copy Download .nbib Format: NLM
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer.

Journal of oncology translational research

Zahra A, Chang T, Hejleh TA, Furqan M, Clamon GH, Bhatia SK, Watkins JM, Mott SL, Ahmann LL, Bodeker KL, Spitz DR, Buatti JM, Allen BG.
PMID: 27981260
J Oncol Transl Res. 2016 Nov;2(1). Epub 2016 Jul 26.

BACKGROUND: To investigate outcomes and prognostic factors in patients treated with once daily high-dose (≥60 Gy) radiation therapy (HDRT) and concurrent platinum-based chemotherapy in limited stage small cell lung cancer (LS-SCLC). While we await current phase III trials to...

Cite
Zahra A, Chang T, Hejleh TA, et al. Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer. J Oncol Transl Res. 2016;2(1)
Zahra, A., Chang, T., Hejleh, T. A., Furqan, M., Clamon, G. H., Bhatia, S. K., Watkins, J. M., Mott, S. L., Ahmann, L. L., Bodeker, K. L., Spitz, D. R., Buatti, J. M., & Allen, B. G. (2016). Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer. Journal of oncology translational research, 2(1), .
Zahra, Amir, et al. "Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer." Journal of oncology translational research vol. 2,1 (2016).
Zahra A, Chang T, Hejleh TA, Furqan M, Clamon GH, Bhatia SK, Watkins JM, Mott SL, Ahmann LL, Bodeker KL, Spitz DR, Buatti JM, Allen BG. Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer. J Oncol Transl Res. 2016 Nov;2(1). Epub 2016 Jul 26. PMID: 27981260; PMCID: PMC5154686.
Copy Download .nbib Format: NLM
A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy.

Annals of radiation therapy and oncology

Mohiuddin IH, Furqan M, Clamon G, Keech J, Anderson C, Smith MC, Buatti JM, Allen BG.
PMID: 30148284
Ann Radiat Ther Oncol. 2017;1(3). Epub 2017 Nov 22.

PURPOSE: Review of our experience in treating thymic carcinoma patients using a combination of surgery, chemotherapy and radiation therapy.METHODS: An institutional review of thymic carcinoma patients treated between 2007 and 2014 was performed analyzing clinical characteristics, treatment intent, surgical...

Cite
Mohiuddin IH, Furqan M, Clamon G, et al. A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy. Ann Radiat Ther Oncol. 2017;1(3)
Mohiuddin, I. H., Furqan, M., Clamon, G., Keech, J., Anderson, C., Smith, M. C., Buatti, J. M., & Allen, B. G. (2017). A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy. Annals of radiation therapy and oncology, 1(3), .
Mohiuddin, Imran H, et al. "A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy." Annals of radiation therapy and oncology vol. 1,3 (2017).
Mohiuddin IH, Furqan M, Clamon G, Keech J, Anderson C, Smith MC, Buatti JM, Allen BG. A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy. Ann Radiat Ther Oncol. 2017;1(3). Epub 2017 Nov 22. PMID: 30148284; PMCID: PMC6103631.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries